Recruiting NA Cerebral Palsy

New treatment option for Cerebral Palsy

Official title Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performance of Children With Cerebral Palsy

ClinicalTrials.gov ID: NCT07432789

What this study is testing

What it's testing
Cerebral palsy is a common neurological disorder that is the leading cause of motor disability in children. It causes significant motor impairments, affecting various aspects such as fine and gross motor skills, as well as locomotion, which has a major impact on the quality of life of affected children.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 6 to 18. Healthy volunteers may be eligible.

You may be able to join if

  • Common to both groups:
  • Obtaining free and informed consent from the child and at least one parent
  • Children of all genders aged 6 to 18
  • Children affiliated with or beneficiaries of a social security system For the Cerebral Palsy group:
  • Medical diagnosis of CP according to the SCPE (Surveillance of Cerebral Palsy in Europe) definition;

You likely can't join if

  • Common to both groups:
  • Participants or parent(s) of participants who do not speak French
  • Children subject to legal protection measures
  • Pregnant or breastfeeding participants For the Cerebral Palsy group:
  • Presence of a cause of neuro-orthopedic disorders other than CP
  • Limiting pain
See the full eligibility criteria
Who can join
  • Common to both groups:
  • Obtaining free and informed consent from the child and at least one parent
  • Children of all genders aged 6 to 18
  • Children affiliated with or beneficiaries of a social security system For the Cerebral Palsy group:
  • Medical diagnosis of CP according to the SCPE (Surveillance of Cerebral Palsy in Europe) definition;
  • Unilateral and bilateral impairment;
  • Gross Motor Function Classification System (GMFCS) = I to III;
  • No major cognitive or visual impairments that limit the performance of motor tasks For the control group: \- Children free from any disease Other volunteers included in the protocol (qualitative analysis only (parents...
  • Parent(s) of children with CP included in this study;
  • Healthcare professionals and researchers involved in monitoring children with CP and/or evaluating the research application within the framework of this study
What rules you out
  • Common to both groups:
  • Participants or parent(s) of participants who do not speak French
  • Children subject to legal protection measures
  • Pregnant or breastfeeding participants For the Cerebral Palsy group:
  • Presence of a cause of neuro-orthopedic disorders other than CP
  • Limiting pain
  • Surgical procedures performed less than 6 months prior to inclusion in the study
  • Any other functional medical intervention that took place 3 months prior to inclusion in the study (e.g., botulinum toxin injections, plaster casts, etc.)
  • Medical or surgical interventions planned between visit 1 and visit 2
  • Children with a condition other than cerebral palsy that affects their walking ability

The study team makes the final eligibility decision.

Where it's taking place

  • Dijon, France

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 6 years to 18 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Dijon, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.